Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4
NCT03578640
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER_GOV
Sponsor class
Conditions
Hepatitis C, Chronic
Interventions
DRUG:
Elbasvir, Grazoprevir 50-100Mg Oral Tablet
Sponsor
King Fahad Medical City